Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF) Reaches New 1-Year Low at $51.60

Recordati Industria Chimica e Farmaceutica S.p.A. (OTCMKTS:RCDTF) shares hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $51.60 and last traded at $51.60, with a volume of 0 shares traded. The stock had previously closed at $51.60.

Recordati Industria Chimica e Farmaceutica Stock Performance

The stock has a market cap of $10.65 billion, a price-to-earnings ratio of 26.74 and a beta of 0.29. The business’s fifty day simple moving average is $51.60 and its 200 day simple moving average is $48.94. The company has a debt-to-equity ratio of 0.80, a current ratio of 1.28 and a quick ratio of 0.86.

Recordati Industria Chimica e Farmaceutica Company Profile

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.